Searched for
STOP TB PARTNERSHIP
Danaher cuts TB diagnosis test cartridge by 20% for high-burden countriesDanaher Corporation announced that it will reduce the price of its Cepheid's Xpert MTB/RIF Ultra diagnostic test cartridges for tuberculosi...- J&J, Lupin cut prices for tuberculosis drug in lower-income countriesJohnson & Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and mi...
- MSF asks Johnson & Johnson to step away from secondary patents for key TB drugMedical charity Medecins Sans Frontieres (MSF) has once again urged Johnson & Johnson (J&J) to not enforce any 'secondary' patents for its ...
- TB drug deal offers short term solution, excludes high burden nations, says health advocacy group“The deal remains just a stop-gap because bedaquiline will only be available to a limited number of countries that will be included in this...
- 'Stop TB' sets ball rolling for Bedaquiline's generic cloneStop TB Partnership has invited tenders for the production of bedaquiline, the first new therapy to be made available for tuberculosis (TB)...
- India develops own model for estimating TB cases in countryIndia has become the first country in the world to have developed a country-level mathematical model to estimate the prevalence of TB cases...
- PM Modi arrives in Varanasi for 'One World TB Summit'During the event, Prime Minister will launch various initiatives including the TB-Mukt Panchayat initiative; the official pan-India rollout...
- Prime Minister Narendra Modi to address 'One World TB Summit' at Varanasi on FridayOn the occasion of World Tuberculosis Day, Modi will address the One World TB Summit being organised by the Ministry of Health and Family W...
- India in advanced stage to deliver on global plan for new TB vaccine by 2025: Mansukh MandaviyaTuberculosis caused 1.6 million deaths globally in 2021, making it the world's leading cause of death from infectious disease, before COVID...
- No one safe until all vaccinated for COVID-19, track hospitalisations, says Johns Hopkins scientistTracking hospitalisation rates which provide an indicator of severity of illness is key, the chief of the Division of Infectious Disease, a...
- Fears of medical shortages and disease in Ukraine after Russian invasionFears of a wider public health crisis are growing as people flee their homes, health services are interrupted and supplies fail to reach Uk...
- TB, Malaria & AIDS toll may rise as focus shifts to Covid-19As per mathematical models, each month of lockdown in India could cause an additional 40,685 deaths between 2020 and 2025 due to TB. India ...
- PM Narendra Modi launches campaign to eradicate TB from India by 2025The prime minister launched the TB-free India Campaign to take the activities under the National Strategic Plan for TB Elimination forward ...
- Keen to use India's brain power, says Paul Stoffels, Chief Scientific Officer, Johnson & JohnsonStoffels, who is also worldwide chairman of the US drug major’s pharmaceuticals group, was in India recently to take stock of company’s ope...
- Three weapons to slow down bacteria spread in hospitalsBeing a scientist, Jayant Halder has just three kinds of weapons: a new drug, a method to tweak old drugs, and a paint that can slow down t...
- We still feel the endless pain of lost lives in 26/11: PM Modi tells SAARC leadersBesides India and Pakistan, the other SAARC countries were Sri Lanka, Nepal, Bangladesh, Bhutan, Maldives and Afghanistan.
- How the economics & politics of tobacco is killing lakhs every yearThe SC has hinted at ‘connivance’ between govt and the tobacco lobby. ITC has made donations to political parties, including Cong and BJP.
- Sunday ET: Why tuberculosis is India's biggest public health problemIndia is home to 2.2 million tuberculosis patients, making it the largest number in a single country.
- On an advocacy missionMichel Sidibe, Executive Director, UNAIDS speaks about what he feels India's role should be going forward.
- India should join global anti-TB plan: WB studyCountries like India and China, with high numbers of TB cases could gain more from the money they spend on diagnosis and treatment of the d...
Load More
